Document is current
Any future updates will be listed below
-
Authors
Damerau, Lukas S
Herold, Robert
Preisser, Alexandra M
Haack, Alena
Petersen, Elina L
Waschki, Benjamin
Magnussen, Christina
Koch, Peter
Nienhaus, Albert
Harth, Volker
Hoven, Hanno
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 17 September 2024
Accepted: 25 March 2025
First Online: 23 April 2025
Declarations
:
: Christina Magnussen received study-specific funding from the German Center for Cardiovascular Research (DZHK; Promotion of Women Scientists Programme; FKZ 81 × 3710112), the Deutsche Stiftung für Herzforschung, the Dr. Rolf M. Schwiete Stiftung, NDD, and Loewenstein Medical, unrelated to the current work. Christina Magnussen also received speaker fees from AstraZeneca, Novartis, Boehringer Ingelheim/Lilly, Bayer, Pfizer, Sanofi, Aventis, Apontis, Abbott, and Novo Nordisk outside this work. Additionally, Christina Magnussen has participated in advisory boards for Boehringer Ingelheim and Novo Nordisk. All other authors declare no competing interests.
: Statement Informed consent was obtained from all subjects involved in the study.
